Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/95BFDAA0.svg?ark=w1%2F20260515%2F95BFDAA0)](https://nobleid.org/work/w1/20260515/95BFDAA0)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors